Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 1

Interventions

pembrolizumab 26 Cisplatin 15 Pemetrexed 14 Paclitaxel 14 Carboplatin 14 Nivolumab 10 Cyclophosphamide 10 Docetaxel 8 atezolizumab 7 Injections 7 Melphalan 6 tislelizumab 5 olaparib 5 Gemcitabine 5 Filgrastim 5 durvalumab 4 aldesleukin 4 Leucovorin 4 Irinotecan 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Bevacizumab 4 tocilizumab 3 spartalizumab 3 liposomal doxorubicin 3 ixabepilone 3 fludarabine 3 epacadostat 3 defactinib 3 adavosertib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × avdoralimab × Other solid neoplasm × Clear all

NCT03665129 2022-01-27

STELLAR-001

Innate Pharma

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡